Cargando…

588. Implementation of a standardized OPAT SmartForm was associated with improved post-discharge outcomes

BACKGROUND: The outpatient parenteral antimicrobial therapy (OPAT) plan has frequently been omitted or incompletely communicated during transitions of care at our institution. Better communication of the OPAT plan at discharge has the potential to improve patient outcomes. METHODS: A standardized OP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Certain, Laura, Benefield, Russell J, Thomas, Frank O
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777607/ http://dx.doi.org/10.1093/ofid/ofaa439.782

Ejemplares similares

748. Does Improving Discharge Documentation Improve Post-Discharge Care for Patients on Outpatient Parenteral Antimicrobial Therapy (OPAT)?
por: Certain, Laura, et al.
Publicado: (2019)

602. Do These Labs Really Matter? Searching for the Benefit of Laboratory Monitoring in Outpatient Parenteral Antimicrobial Therapy (OPAT)
por: Zukauckas, Kelsea N, et al.
Publicado: (2020)

606. Implementation of a Telehealth-based OPAT Early Post-Discharge Clinic May Reduce Hospital Readmission
por: Cortes-Penfield, Nicolas W, et al.
Publicado: (2021)

232. Safety and Effectiveness of Intravenous to Oral De-escalation Compared to Continued Vancomycin Therapy in Orthopedic Infections
por: Gallagher, Chanah, et al.
Publicado: (2021)

604. Factors Associated with Adverse Drug Reactions Leading to Discontinuation of Vancomycin in Outpatient Parenteral Antimicrobial Therapy
por: McDonald, Josh, et al.
Publicado: (2020)

618. Post-discharge Care Coordination Telephone Call for Patients Enrolled in the UNC OPAT Program
por: Boerneke, Renae A, et al.
Publicado: (2020)

909. Impact of Implementing an IV to PO Antibiotic Treatment Protocol for Orthopedic Infections on Prescribing Habits and Health Utilization Outcomes
por: Gallagher, Chanah, et al.
Publicado: (2022)

1290. Impact of Implementing an IV to PO Antibiotic Treatment Protocol for Orthopedic Infections
por: Gray, Julie, et al.
Publicado: (2023)

624. Significant Institutional Cost Savings from OPAT-Facilitated Discharge for Patients with Challenging Situations
por: Alexander, Bryan, et al.
Publicado: (2020)

2214. Retrospective Analysis of the Implementation of a Novel Discharge Reconciliation service in OPAT by Pharmacists (RAINDROP)
por: Caverzagie, Brady, et al.
Publicado: (2023)

Pro SAP scripts, smartforms, and data migration: ABAP programming simplified
por: Markandeya, Sushil
Publicado: (2017)

608. Continuous Infusion Vancomycin Is Not Associated with Improved Safety in an Outpatient Parenteral Antimicrobial Therapy Program
por: Tagare, Rosemarie D, et al.
Publicado: (2021)

483. OPAT Delivery during COVID-19
por: Swartwood, Michael J, et al.
Publicado: (2020)

28. The Paradox of an Integrated MAT OPAT Program
por: Eckardt, Paula, et al.
Publicado: (2021)

1829. The Impact of Social Determinants of Health on Treatment Route, Duration, and Outcomes in Bone and Joint Infections
por: Cummins, Heather, et al.
Publicado: (2023)

627. Tele-OPAT Outcomes at Two Community Hospitals
por: Sheridan, Kathleen R, et al.
Publicado: (2020)

316. Leveraging the Electronic Health Record to Improve OPAT Discharges at University of Colorado Hospital
por: Allen, Lorna, et al.
Publicado: (2023)

607. Identifying Intervention Opportunities to Prevent Readmissions during OPAT
por: Swartwood, Michael J, et al.
Publicado: (2020)

625. Sustained Efforts Improve Adherence to Monitoring for Solid Tumor Patients Discharged on Outpatient Parenteral Antimicrobial Therapy (OPAT) at a Comprehensive Cancer Center
por: Robins, Alison, et al.
Publicado: (2020)

Utilizing a Post-discharge Telephone Call in Outpatient Parenteral Antimicrobial Therapy (OPAT): Findings from a Quality Improvement Project
por: Felder, Kimberly, et al.
Publicado: (2017)

588. Are Popliteal Vein PICCs safe for Neonates?
por: Lochner, Harold J, et al.
Publicado: (2019)

592. A Pilot Program to Evaluate Home Telemedicine Visits in an OPAT Program
por: Sheridan, Kathleen R, et al.
Publicado: (2020)

623. Self-Administered Outpatient Parenteral Antimicrobial Therapy (S-OPAT) in Uninsured Patients
por: Hamad, Yasir, et al.
Publicado: (2020)

600. Decreased Hospital Readmission After Programmatic Strengthening of an Outpatient Parenteral Antimicrobial Therapy (OPAT) Program
por: Agnihotri, Gaurav, et al.
Publicado: (2020)

619. Current State of Infectious Diseases Pharmacist OPAT/COpAT Practice in the United States
por: Rivera, Christina G, et al.
Publicado: (2021)

P13 Every patient who could have OPAT, should have OPAT—the importance of data
por: Williams, Steph, et al.
Publicado: (2022)

202. Implementation of an Outpatient Parenteral Antimicrobial Therapy (OPAT) Collaborative for Patients with Staphylococcus aureus or Gram-Negative Bacilli Bacteremia Requiring Home Infusion: The PANTHIR Program
por: Ross, Jennifer K, et al.
Publicado: (2020)

591. A Model for assessing staffing needs for an Outpatient Parenteral Antibiotic Therapy (OPAT) program
por: Munsiff, Sonal, et al.
Publicado: (2020)

339. OPAT Outcomes in Patients with Immunocompromise
por: Mahoney, Monica V, et al.
Publicado: (2023)

336. A 6-Sigma Approach for Follow-up Evaluation of Outpatient Parenteral Antimicrobial Therapy (Project SAFE-OPAT) To Improve Documentation and Post-Discharge Care
por: Keri, Vishakh C, et al.
Publicado: (2023)

609. Implementation and Post-implementation Analysis of a Pilot Program for Inpatient Review of Outpatient Parenteral Antimicrobial Therapy Prior to Discharge
por: Hart, Delaney, et al.
Publicado: (2020)

1829. Dalbavancin versus standard of care as directed therapy for Staphylococcus aureus bacteremia in patients unable to receive OPAT
por: Frazier, J, et al.
Publicado: (2022)

767. Can Integration of Addiction Treatment Facilitate Safe Discharge on OPAT for Patients with Infectious Complications of Injection Drug Use?
por: Solomon, Daniel A, et al.
Publicado: (2019)

621. Identifying Quality-Improvement Interventions to Improve Inpatient Intravenous Vancomycin Safety at an Academic Medical Center
por: Christensen, Sean, et al.
Publicado: (2021)

610. Incidence of Acute Kidney Injury in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Vancomycin
por: Hamad, Yasir, et al.
Publicado: (2020)

217. Broad Spectrum Antibiotic use in Outpatient Parenteral Antibiotic Therapy (OPAT): Opportunities for Antibiotic Stewardship
por: Brenon, Jessa R, et al.
Publicado: (2020)

625. The Hidden Cost of Dalbavancin: OPAT-RN Time Spent on Coordination for Patients with Substance Use Disorder
por: Douglass, Alyse, et al.
Publicado: (2021)

1205. Protectin D1 Induced by Clostridium butyricum MIYAIRI 588 Has an Anti-inflammatory Effects on Antibiotic-induced Intestinal Disorder
por: Ariyoshi, Tadashi, et al.
Publicado: (2020)

1923. OPAT or No-PAT? Evaluation of Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Daptomycin or Ertapenem for “Ease of Administration”
por: Britt, Rachel S, et al.
Publicado: (2018)

Outpatient Parenteral Antibiotic Therapy (OPAT) Serial Readmissions and High Utilizers: Drilling Down on Readmission Following Discharge on Intravenous Antibiotics
por: Andrews, Mary-Margaret, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pbhutbf17psjf49sahrbj5sk0t